Full history for every metric is available with a Kvantra account
Xybion Digital Inc. (XYBN.V)
Key financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | 14 | 15 | 14 | 17 | 16 | 17 |
| Operating profit | $m | -2 | 2 | |||||
| Net profit | $m | - | 2 | 1 | 2 | -1 | -1 | 1 |
| EPS reported | $ | -0.84 | -0.15 | |||||
| Operating cashflow per share | $ | -1.38 | -1.38 | |||||
| Capex per share | $ | 0.02 | 0.02 | |||||
| FCF per share | $ | -1.40 | -1.40 | |||||
| Free cash flow | $m | -2 | 4 | |||||
| Net debt | $m | -4 | 1 | |||||
| Book value equity | $m | 8 | 9 | |||||
| Book value per share | $ | 4.95 | 5.49 | |||||
| Number of shares | m | 1.59 | 1.61 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.28 | 3.74 | |||||
| P/S LTM | x | 0.13 | 1.91 | |||||
| P/FCF LTM | x | -1.03 | 7.93 | |||||
| EV/EBITDA LTM | x | 1.71 | 11.57 | |||||
| EV/Sales LTM | x | -0.13 | 1.98 | |||||
| Earnings Yield LTM | % | -60.27% | -137.54% | |||||
| FCF Yield | % | -96.88% | 12.61% | |||||
| Quality | ||||||||
| ROE | % | -16.95% | -15.49% | |||||
| ROIC | % | -14.54% | -14.54% | |||||
| Operating margin | % | -10.17% | -10.17% | |||||
| Gross margin | % | 63.16% | 63.16% | |||||
| FCF/Sales | % | -13.01% | -13.01% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -1.98% | +4.56% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -2.38 | 0.41 | |||||
| Net Debt/EBITDA | x | 3.44 | 3.44 | |||||
| EBIT/Net interest | x | -167.06 | -167.06 | |||||
| Net debt/market cap | % | -199.01% | 3.67% | |||||
| Net debt/Equity | x | -0.56 | 0.14 | |||||
| Gross debt/equity | x | 0.11 | 1.15 | |||||
Company overview
Xybion Digital Inc. is a software-as-a-service (SaaS) provider offering a comprehensive suite of digital solutions to life sciences and health systems organizations worldwide. Their product portfolio addresses various critical needs, including integrated laboratory execution systems like Pristima XD, Labwise XD for managing GMP and non-GMP compliant lab operations, and specialized digital pathology software. The company also provides Savante for data warehousing, analytics, and SEND management. A core area of their expertise lies in compliance, quality, and risk management, featuring platforms such as CQRM XD, a unified cloud-based system for predictive compliance, quality, and risk; Compliance Risk Predictor for mitigating compliance risks; and Compliance Builder for real-time monitoring. This segment also includes comprehensive quality management solutions like CQRM XD Quality Management and QMS OpenText. Additionally, Xybion provides solutions for workforce health and safety, including Emidence XD and a COVID-19 test management application, alongside ECM XD for cloud-based enterprise content management. Beyond their software, they offer professional services such as project management, computer system validation, and software development and testing. While primarily serving life sciences, Xybion Digital caters to a diverse range of industries, including workplace health and safety, transportation, energy, financial services, enterprise solutions, healthcare, insurance, and government sectors. The company is headquartered in Princeton, New Jersey, and operates as a subsidiary of Banerjee Group LLC.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Xybion Digital Inc. (XYBN.V)
Xybion Digital Inc. is a software-as-a-service (SaaS) provider offering a comprehensive suite of digital solutions to life sciences and health systems organizations worldwide. Their product portfolio addresses various critical needs, including integrated laboratory execution systems like Pristima XD, Labwise XD for managing GMP and non-GMP compliant lab operations, and specialized digital pathology software. The company also provides Savante for data warehousing, analytics, and SEND management. A core area of their expertise lies in compliance, quality, and risk management, featuring platforms such as CQRM XD, a unified cloud-based system for predictive compliance, quality, and risk; Compliance Risk Predictor for mitigating compliance risks; and Compliance Builder for real-time monitoring. This segment also includes comprehensive quality management solutions like CQRM XD Quality Management and QMS OpenText. Additionally, Xybion provides solutions for workforce health and safety, including Emidence XD and a COVID-19 test management application, alongside ECM XD for cloud-based enterprise content management. Beyond their software, they offer professional services such as project management, computer system validation, and software development and testing. While primarily serving life sciences, Xybion Digital caters to a diverse range of industries, including workplace health and safety, transportation, energy, financial services, enterprise solutions, healthcare, insurance, and government sectors. The company is headquartered in Princeton, New Jersey, and operates as a subsidiary of Banerjee Group LLC.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free